Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$306.88 - $380.0 $3,989 - $4,940
-13 Reduced 1.3%
990 $375,000
Q3 2023

Nov 14, 2023

SELL
$315.92 - $397.36 $49,915 - $62,782
-158 Reduced 13.61%
1,003 $319,000
Q2 2023

Aug 15, 2023

SELL
$346.15 - $392.09 $833,529 - $944,152
-2,408 Reduced 67.47%
1,161 $445,000
Q1 2023

May 15, 2023

SELL
$323.56 - $373.36 $20,384 - $23,521
-63 Reduced 1.73%
3,569 $1.33 Million
Q4 2022

Feb 15, 2023

BUY
$248.67 - $334.17 $2,238 - $3,007
9 Added 0.25%
3,632 $1.2 Million
Q3 2022

Nov 14, 2022

SELL
$263.81 - $337.27 $274,626 - $351,098
-1,041 Reduced 22.32%
3,623 $956,000
Q2 2022

Aug 15, 2022

BUY
$301.4 - $428.42 $78,364 - $111,389
260 Added 5.9%
4,664 $1.46 Million
Q1 2022

May 16, 2022

BUY
$379.46 - $424.54 $65,267 - $73,020
172 Added 4.06%
4,404 $1.84 Million
Q4 2021

Feb 15, 2022

SELL
$373.53 - $434.12 $93,756 - $108,964
-251 Reduced 5.6%
4,232 $1.77 Million
Q3 2021

Nov 15, 2021

SELL
$396.76 - $455.92 $39,676 - $45,592
-100 Reduced 2.18%
4,483 $1.85 Million
Q2 2021

Aug 16, 2021

SELL
$372.36 - $412.07 $53,619 - $59,338
-144 Reduced 3.05%
4,583 $1.82 Million
Q1 2021

May 17, 2021

SELL
$357.26 - $392.57 $925,303 - $1.02 Million
-2,590 Reduced 35.4%
4,727 $1.82 Million
Q4 2020

Feb 16, 2021

SELL
$319.05 - $363.32 $27,119 - $30,882
-85 Reduced 1.15%
7,317 $2.66 Million
Q3 2020

Nov 16, 2020

SELL
$280.08 - $347.78 $9,802 - $12,172
-35 Reduced 0.47%
7,402 $2.5 Million
Q2 2020

Aug 14, 2020

SELL
$270.93 - $320.3 $237,334 - $280,582
-876 Reduced 10.54%
7,437 $2.11 Million
Q1 2020

May 13, 2020

BUY
$243.44 - $359.98 $110,765 - $163,790
455 Added 5.79%
8,313 $2.29 Million
Q4 2019

Feb 12, 2020

BUY
$281.18 - $322.05 $2.21 Million - $2.53 Million
7,858 New
7,858 $2.53 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.